Marina Garassino

Università degli Studi di Torino

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (7)

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (7)

Everett E. Vokes

University of Chicago

UNITED STATES

View details

Christine Bestvina

Assistant Professor

University of Chicago Medicine

UNITED STATES

View details

Christian Rolfo

Professor, Assoc. Director of Clinical Research

Mount Sinai Hospital

UNITED STATES

View details

Jonathan W. Goldman

Associate Professor

UCLA

UNITED STATES

View details

Silvia NOVELLO

Professor

Università degli Studi di Torino

ITALY

View details

Johan Vansteenkiste

Professor

Catholic University of Leuven

BELGIUM

View details

ENRIQUETA FELIP

Head Thoracic Oncology Unit (After Competitive Exam)

Hospital Universitari Vall d'Hebron

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Marina Garassino

Research Interests

Explore related searches

Contact this professor

Articles (7)

Durvalumab ± Tremelimumab + Platinum-Etoposide in Extensive-Stage Small Cell Lung Cancer (CASPIAN): Outcomes by PD-L1 Expression and Tissue Tumor Mutational Burden

Early-Stage Lung Cancer: Using Circulating Tumor DNA to Get Personal

Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non–Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study

Poziotinib in Non–Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutations After Prior Therapies: ZENITH20-2 Trial

Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

The Armed Conflict and the Impact on Patients With Cancer in Ukraine: Urgent Considerations

Patient-reported outcomes with durvalumab by PD-L1 expression and prior chemoradiotherapy-related variables in unresectable stage III non-small-cell lung cancer

Collaborators (7)

Everett E. Vokes

Christine Bestvina

Christian Rolfo

Jonathan W. Goldman

Silvia NOVELLO

Johan Vansteenkiste

ENRIQUETA FELIP

Make your next move.